IL1B and COVID-19: The authors of the original study showed that the SARS-CoV‐2 S protein primes inflammasome formation and the release of mature IL1β in macrophages derived from COVID‐19 patients, but not in macrophages from healthy SARS‐CoV‐2-naïve individuals.